IDEXX Laboratories reported a strong quarter with significant revenue and profit growth driven by robust international performance and record instrument placements. However, the U.S. market faced challenges with declining clinical visits and some pressure on rapid assay revenues. The company remains confident in its innovation-driven strategy and increased its full-year guidance, signaling optimism despite ongoing macroeconomic challenges.

Company Guidance -

Q3 2025

During the IDEXX Laboratories Second Quarter 2025 Earnings Conference Call, strong financial results were reported, driven by significant growth in the Companion Animal Group (CAG) business. The company saw an 11% increase in revenue as reported and 9% growth organically, with CAG Diagnostic Recurring Revenues growing nearly 7.5% organically. This was offset by a 2.5% decline in U.S. same-store clinical visits. Operating profit grew by 14% on a comparable basis, contributing to an earnings per share (EPS) of $3.63, marking a 17% increase. IDEXX raised its full-year revenue outlook to a range of $4,205 million to $4,280 million, reflecting a 7.7% to 9.7% expected growth. Organic revenue is projected to grow between 7% and 9%, with CAG Diagnostic recurring revenue growth estimated at 5.8% to 8%. The company's EPS outlook was also increased to $12.40 to $12.76 per share, indicating growth of 9% to 13% for the full year.

Strong Revenue Growth

IDEXX delivered revenue growth of 11% as reported and 9% organically in Q2 2025, driven by nearly 7.5% organic growth in CAG Diagnostic Recurring Revenues, with double-digit expansion in international regions.

Record Instrument Placements

The company placed nearly 2,400 IDEXX inVue DX instruments, marking a record quarter for premium instrument placements, which contributed to the strong revenue performance.

Operating Profit and EPS Increase

Operating profit grew by 14% on a comparable basis, leading to an EPS growth of 17% on a comparable basis, with EPS reaching $3.63 in the quarter.

Increased Full Year Guidance

IDEXX increased its full-year revenue outlook by $90 million at midpoint and raised its EPS guidance to $12.40 to $12.76 per share, reflecting 9% to 13% full-year comparable EPS growth.

International Expansion Success

International regions saw 11% organic gains, marking the tenth consecutive quarter of double-digit installed base growth in CAG Diagnostics.

Idexx Laboratories (IDXX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

IDXX Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 04, 2025	2025 (Q3)	3.13 / -	2.8	―	―	―
Aug 04, 2025	2025 (Q2)	3.30 / 3.63	2.44	48.77% (+1.19)
May 01, 2025	2025 (Q1)	2.85 / 2.96	2.81	5.34% (+0.15)
Feb 03, 2025	2024 (Q4)	2.40 / 2.62	2.32	12.93% (+0.30)
Oct 31, 2024	2024 (Q3)	2.68 / 2.80	2.53	10.67% (+0.27)
Aug 06, 2024	2024 (Q2)	2.88 / 2.44	2.67	-8.61% (-0.23)
May 01, 2024	2024 (Q1)	2.71 / 2.81	2.55	10.20% (+0.26)
Feb 05, 2024	2023 (Q4)	2.12 / 2.32	2.05	13.17% (+0.27)
Nov 01, 2023	2023 (Q3)	2.37 / 2.53	2.15	17.67% (+0.38)
Aug 01, 2023	2023 (Q2)	2.47 / 2.67	1.56	71.15% (+1.11)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

IDXX Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 04, 2025	$535.54	$682.78	+27.49%
May 01, 2025	$432.65	$471.38	+8.95%
Feb 03, 2025	$422.05	$469.04	+11.13%
Oct 31, 2024	$451.08	$406.92	-9.79%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Idexx Laboratories (IDXX) report earnings?

Idexx Laboratories (IDXX) is schdueled to report earning on Nov 04, 2025, Before Open (Confirmed).

What is Idexx Laboratories (IDXX) earnings time?

Idexx Laboratories (IDXX) earnings time is at Nov 04, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is IDXX EPS forecast?

IDXX EPS forecast for the fiscal quarter 2025 (Q3) is 3.13.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing